Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease
- 1 March 2002
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 112 (4), 269-274
- https://doi.org/10.1016/s0002-9343(01)01115-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Stable versus unstable atherosclerosis: Clinical aspectsAmerican Heart Journal, 1999
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Pathophysiology and clinical significance of atherosclerotic plaque ruptureCardiovascular Research, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional studyBMJ, 1996
- Molecular Bases of the Acute Coronary SyndromesCirculation, 1995
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994